search
Back to results

Endoscopic Classification and DISE-Guided Surgery in Pediatric Obstructive Sleep-Disordered Breathing. (DISE)

Primary Purpose

Obstructive Sleep Apnea of Child

Status
Not yet recruiting
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
Drug-induced Sleep Endoscopy findings (identified obstruction sites)
Sponsored by
Regional Hospital West Jutland
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Obstructive Sleep Apnea of Child focused on measuring Drug-induced Sleep Endoscopy

Eligibility Criteria

2 Years - 12 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Surgically naïve, otherwise healthy, non-syndromic children aged 2-12 years with suspected oSDB of any severity One completed Pediatric Sleep Questionnaire - Sleep Related Breathing Disorder (PSQ) Home Respiratory Polygraphy (HRP) and/or in-house Polysomnography (PSG) showing OSA according to the definition of AAO-HNSF Exclusion Criteria: Syndromes and congenital/acquired craniofacial abnormalities/malformations of the upper airways Neurological conditions affecting upper airway muscle tone Lower airway disease (tracheomalacia, asthma) Previous surgery of the nose/pharynx/larynx

Sites / Locations

  • Regional Hospital Gødstrup

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

DISE-guided treatment group

Non-DISE-guided treatment group

Arm Description

DISE findings will be documented and obstruction scored per pediatric DISE criteria. Clinically relevant obstruction is defined as >50% at minimum one site. (Adeno-)tonsillotomy will be performed if corroborative DISE suggests tonsil/adenoid obstruction; if not, no surgery will be performed. This approach is maintained despite other identified obstruction sites, which will be assessed at a later stage.

DISE findings will be documented, and video material will be saved for later assessment. Patients will be operated according to current guidelines (s.o.), regardless of perioperative DISE findings, i.e. tonsillotomy +/- adenoidectomy.

Outcomes

Primary Outcome Measures

Treatment Failure Rate
Proportion of patients, who exhibit persistent OSA post-surgery in the DISE-guided surgery group compared to the non-DISE-guided surgery group (controls).

Secondary Outcome Measures

DISE findings
Evaluation of DISE findings and pediatric VOTE: Assessing obstruction degree and sites in both groups. Quality of Life Improvement: DISE-score and Airway Obstruction Pattern: Identifying and comparing anatomical obstruction sites and severity during DISE in both groups.
OSA (AHI)
Change in apnea-hypopnea index (AHI): Analyzing AHI and oxygen saturation differences between baseline and post-treatment in both groups.
Quality of Life (OSA-18)
Evaluation of symptom changes and quality of life using the OSA-18 questionnaire in both groups.
Sedation-related and surgical complications
Adverse Events and Complications: Investigation of the incidence and severity of sedation-related events and surgical complications in both groups, including postoperative hemorrhage, infection, recurrent symptoms post-tonsillotomy, and symptom improvement without treatment.

Full Information

First Posted
October 11, 2023
Last Updated
October 17, 2023
Sponsor
Regional Hospital West Jutland
Collaborators
University Hospital, Antwerp
search

1. Study Identification

Unique Protocol Identification Number
NCT06093802
Brief Title
Endoscopic Classification and DISE-Guided Surgery in Pediatric Obstructive Sleep-Disordered Breathing.
Acronym
DISE
Official Title
Endoscopic Classification of Airway Obstruction and Drug Induced Sleep Endoscopy-Guided Surgery in Children With Obstructive Sleep-Disordered Breathing.
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
January 1, 2025 (Anticipated)
Primary Completion Date
January 1, 2026 (Anticipated)
Study Completion Date
July 1, 2029 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Regional Hospital West Jutland
Collaborators
University Hospital, Antwerp

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Pediatric obstructive sleep apnea (OSA) can lead to severe health issues if untreated. While polysomnography is the gold standard for diagnosis, current surgical treatment in Denmark relies on caregiver reports and clinical exams. Approximately 25% of patients have persistent symptoms post-surgery, indicating the need for better diagnostic and treatment options. Drug-Induced Sleep Endoscopy (DISE) allows dynamic upper airway visualization during mild sedation, aiding in treatment decisions. This research project aims to evaluate the impact of DISE-guided interventions on pediatric OSA outcomes and compare its effectiveness and cost/benefit with traditional diagnostic approaches.
Detailed Description
Background 1.1 Pediatric Obstructive Sleep Apnea Pediatric OSA ranges from simple snoring to severe upper airway obstruction during sleep. Left untreated, it can lead to significant health issues, especially in children, impacting their cognitive development, learning, and social interactions. 1.2 Diagnostics and Surgical Strategies Polysomnography (PSG) is the gold standard for diagnosing OSA. In Denmark, PSG isn't widely used due to equipment and setup constraints. Surgical treatment for pediatric OSA in Denmark relies primarily on clinical examination of the tonsils and parental reports of symptoms. 1.3 Drug-Induced Sleep Endoscopy (DISE) DISE is a method for visualizing upper airway collapse during sleep using a flexible endoscope. It is increasingly used to guide surgical decisions for pediatric OSA in various countries, though its clinical impact remains uncertain. 2. Aims This research project aims to evaluate the impact of DISE-guided surgical interventions on pediatric OSA outcomes and compare the effectiveness of a DISE-inclusive diagnostic approach with the traditional pediatric OSA workup. The specific objectives are: Evaluate treatment outcomes, including the reduction in persistent OSA post-surgery. Classify and compare patterns of airway obstruction observed during DISE in surgically naive children. Compare diagnostic approaches in terms of cost, time, and benefits. Identify adverse events and complications related to sedation and surgery. Assess the feasibility of DISE in Danish patients through a pilot study. 3. Methods 3.1 Randomized Controlled Trial (RCT) Patients undergo initial clinical examination and home respiratory polygraphy (HRP). Based on AAO-HNSF criteria, patients with OSA will undergo DISE. The sample size for the RCT is 250 patients, with 125 in each group. 3.2 Statistics Statistical analysis will involve Chi-square tests, logistic regression, and T-tests for comparisons between groups. 3.3 Sedation Protocol Sedation will use propofol to induce a state similar to natural sleep, guided by preoperative polysomnography. 3.4 Assessment of Obstruction Obstruction characteristics will be documented using the International Pediatric Sleep Endoscopy Scale (IPSES). 3.5 Follow-up Patients will have two follow-up appointments at three and 12 months postoperatively, including clinical examination, HRP, and re-DISE at three months for both groups. 4. Outcomes 4.1 Primary Outcome The primary outcome is the treatment failure rate, comparing the proportion of patients with persistent OSA post-surgery in the DISE-guided surgery group to the non-DISE-guided surgery group. 4.2 Secondary Outcomes Secondary outcomes include evaluation of DISE findings, changes in apnea-hypopnea index (AHI), quality of life improvement, DISE-score/airway obstruction pattern, and identification of adverse events and complications. 4.3 Confounding Factors Population characteristics, such as age, obesity (BMI), and gender, will be considered. 5. Ethical Considerations In cases where no obstruction is identified related to tonsils or adenoids, alternative treatment options will be discussed with parents. Privacy and informed consent are required. The study will follow ethical and data protection regulations

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obstructive Sleep Apnea of Child
Keywords
Drug-induced Sleep Endoscopy

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
InvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
250 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
DISE-guided treatment group
Arm Type
Experimental
Arm Description
DISE findings will be documented and obstruction scored per pediatric DISE criteria. Clinically relevant obstruction is defined as >50% at minimum one site. (Adeno-)tonsillotomy will be performed if corroborative DISE suggests tonsil/adenoid obstruction; if not, no surgery will be performed. This approach is maintained despite other identified obstruction sites, which will be assessed at a later stage.
Arm Title
Non-DISE-guided treatment group
Arm Type
Active Comparator
Arm Description
DISE findings will be documented, and video material will be saved for later assessment. Patients will be operated according to current guidelines (s.o.), regardless of perioperative DISE findings, i.e. tonsillotomy +/- adenoidectomy.
Intervention Type
Diagnostic Test
Intervention Name(s)
Drug-induced Sleep Endoscopy findings (identified obstruction sites)
Other Intervention Name(s)
Turbinoplasty, Nasal steroids
Intervention Description
As described above
Primary Outcome Measure Information:
Title
Treatment Failure Rate
Description
Proportion of patients, who exhibit persistent OSA post-surgery in the DISE-guided surgery group compared to the non-DISE-guided surgery group (controls).
Time Frame
one year post surgery
Secondary Outcome Measure Information:
Title
DISE findings
Description
Evaluation of DISE findings and pediatric VOTE: Assessing obstruction degree and sites in both groups. Quality of Life Improvement: DISE-score and Airway Obstruction Pattern: Identifying and comparing anatomical obstruction sites and severity during DISE in both groups.
Time Frame
initial assessment and one year post surgery
Title
OSA (AHI)
Description
Change in apnea-hypopnea index (AHI): Analyzing AHI and oxygen saturation differences between baseline and post-treatment in both groups.
Time Frame
initial assessment and one year post surgery
Title
Quality of Life (OSA-18)
Description
Evaluation of symptom changes and quality of life using the OSA-18 questionnaire in both groups.
Time Frame
initial assessment and one year post surgery
Title
Sedation-related and surgical complications
Description
Adverse Events and Complications: Investigation of the incidence and severity of sedation-related events and surgical complications in both groups, including postoperative hemorrhage, infection, recurrent symptoms post-tonsillotomy, and symptom improvement without treatment.
Time Frame
initial assessment and one year post surgery

10. Eligibility

Sex
All
Minimum Age & Unit of Time
2 Years
Maximum Age & Unit of Time
12 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Surgically naïve, otherwise healthy, non-syndromic children aged 2-12 years with suspected oSDB of any severity One completed Pediatric Sleep Questionnaire - Sleep Related Breathing Disorder (PSQ) Home Respiratory Polygraphy (HRP) and/or in-house Polysomnography (PSG) showing OSA according to the definition of AAO-HNSF Exclusion Criteria: Syndromes and congenital/acquired craniofacial abnormalities/malformations of the upper airways Neurological conditions affecting upper airway muscle tone Lower airway disease (tracheomalacia, asthma) Previous surgery of the nose/pharynx/larynx
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Mascha Hildebrandt, MD
Phone
+4541289051
Email
mascha.hilde@gmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Jannik Bertelsen, MD PhD
Email
jannik.bertelsen@auh.rm.dk
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Therese E Ovesen, Prof. DMSc
Organizational Affiliation
Regional Hospital West Jutland
Official's Role
Study Director
Facility Information:
Facility Name
Regional Hospital Gødstrup
City
Herning
State/Province
Region Of Central Jutland
ZIP/Postal Code
7400
Country
Denmark
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Therese E Ovesen, Prof. DMSc
Email
theroves@rm.dk
First Name & Middle Initial & Last Name & Degree
Anne Louise Bach Christensen, MD
Email
anebch@rm.dk

12. IPD Sharing Statement

Plan to Share IPD
Undecided

Learn more about this trial

Endoscopic Classification and DISE-Guided Surgery in Pediatric Obstructive Sleep-Disordered Breathing.

We'll reach out to this number within 24 hrs